Carla Rodriguez-Watson

Reagan-Udall Foundation for the FDA

Poster(s):

• (A-209) Developing Validation Tool for Claim-Based Pregnancy Outcomes: The Pregnancy Algorithm CErtaInty Tool (Pregnancy ACE-IT)
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-313) Post-authorization Safety Study to Assess the Risk of Diabetic Ketoacidosis among Type 2 Diabetes Mellitus Patients Treated with Ertugliflozin Compared to Patients Treated with Other Antihyperglycemic Agents
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET